JAMA Medical News

Stephen Fihn, a former leader in the VA’s electronic health record initiatives and a professor at the University of Washington, shares invaluable insights from nearly four decades in the field. He discusses the VA's pioneering role in adopting EHRs, highlighting initial clinician resistance and strategies to enhance patient care. Fihn explores the evolution of AI in healthcare, emphasizing the importance of ongoing model recalibration amid challenges like data drift. He also outlines future opportunities for EHRs to streamline healthcare decisions and improve patient interactions.

European Society of Cardiology Vice President Carlos Aguiar, MD, discusses clinical research highlights from the largest scientific meeting in cardiovascular medicine, held recently in London. Updates include semaglutide findings, hypertension triple pills, and more. Related Content: Semaglutide Updates, Hypertension Triple Pills, and More—Heart Health Highlights From ESC Congress

Related Content: The Latest Research About Paxlovid: Effectiveness, Access, and Possible Long COVID Benefits New Guidance Helps Clinicians Use Pemivibart to Protect Immunocompromised Patients From COVID-19

Quarraisha Abdool Karim, PhD, and Salim S. Abdool Karim, MBChB, PhD, are the recipients of the 2024 Lasker-Bloomberg Public Service Award for their decades of work on AIDS in Africa. The infectious diseases epidemiologists recently reflected on their life’s work in a conversation with JAMA Deputy Editor and infectious diseases physician Preeti Malani, MD, MSJ. Related Content: Thirty-Five Years of HIV Research in Africa—An Interview With Winners of the 2024 Lasker-Bloomberg Public Service Award AIDS in Africa—Impact of Research

Join emergency medicine physician Jeremy Hess from the University of Washington and former Oregon emergency management director Andrew Phelps as they discuss the shocking 2021 heat dome. They dive into the rising health risks due to extreme heat and lessons learned about public safety during crises exacerbated by climate change. Discover the challenges cooling centers faced, the rise in unaccompanied deaths among vulnerable populations, and the urgent need for better preparedness and community resilience against future heat waves.

Here’s What to Know About the New Mpox Global Emergency; Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Related Content: As Mpox Cases Surge in Africa, WHO Declares a Global Emergency—Here’s What to Know Controversial FDA Decision Authorizes Menthol-Flavored E-Cigarettes Despite Risks to Youth

Sebastian Palmqvist, MD, PhD, and Wiesje van der Flier, PhD, are cochairs of the 2024 Alzheimer’s Association International Conference, while Rita Rubin serves as Lead Senior Staff Writer for JAMA Medical News. They delve into exciting topics like a groundbreaking blood test for Alzheimer’s, the repurposing of GLP-1 receptor agonists, and potential risks from inhaling wildfire smoke. They also discuss the importance of blood-based biomarkers and advancements in Alzheimer’s diagnosis and treatment, emphasizing the need for responsible implementation in clinical settings.

In this thought-provoking discussion, Vivek H. Murthy, the US Surgeon General, emphasizes the alarming impact of social media on youth mental health, particularly its role in the loneliness epidemic. He reveals the rising tide of anxiety and depression linked to social platform use. The conversation navigates the necessity for warning labels, comparing it to tobacco regulation, and stresses the importance of transparency from tech companies. Parents and clinicians are given practical strategies to foster healthier social media habits in children.

Which Variant Will Updated COVID-19 Vaccines Target This Fall? COVID-19 May Protect Against the Common Cold Related Content: Picking the Optimal Variant to Target in Updated COVID-19 Vaccines Is Tricky COVID-19 May Protect Against the Common Cold—Here’s Why Knowing That Could Lead to Better Vaccines

Dr. Robert Gabbay, an endocrinologist and chief scientific officer at the ADA, shares insights on groundbreaking diabetes research. He discusses impressive advancements in weight loss medications and the innovation of GLP-1 receptor agonists for kidney health and diabetes prevention. The talk highlights the new potential for inhaled insulin and the importance of continuous glucose monitoring technology. Dr. Gabbay also emphasizes the need for combining medication with lifestyle changes, all amidst exciting collaborations between academia and startups.